Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease

Hepatology

Volumn 53, Issue 3, 2011, Pages 1064-1065

  Witters, Peter ^a,b   Libbrecht, Louis ^b,c   Roskams, Tania ^a   Boeck, Kris De ^a   Dupont, Lieven ^a   Proesmans, Marijke ^a   Vermeulen, François ^a   Strandvik, Birgitta ^d   Lindblad, Anders ^e   Stéphenne, Xavier ^f   Sokal, Etienne ^f   Gosseye, Serge ^f   Heye, Sam ^a   Maleux, Geert ^a   Aerts, Raymond ^a   Monbaliu, Diethard ^a   Pirenne, Jacques ^a   Hoffman, Ilse ^a   Nevens, Frederik ^a,b   Cassiman, David ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS; ESOPHAGUS VARICES; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; MICROTHROMBUS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA;

BIOPSY; CYSTIC FIBROSIS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; PORTAL VEIN; RETROSPECTIVE STUDIES;

EID: 79952215545     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24183     Document Type: Letter

References (7)

1. Lewindon PJ, Shepherd RW, Walsh MJ, Greer RM, Williamson R, Pereira TN, et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. HEPATOLOGY 2010; doi:10.1002/hep.24014.
2. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009; 6: 573-582.
3. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. HEPATOLOGY 1998; 28: 323-331.
4. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. HEPATOLOGY 1999; 30: 1151-1158.
5. Wanless IR. Understanding noncirrhotic portal hypertension: ménage à fois. HEPATOLOGY 1988; 8: 192-193.
6. O'Sullivan BP, Linden MD, Frelinger AL3rd, Barnard MR, Spencer-Manzon M, Morris JE, et al. Platelet activation in cystic fibrosis. Blood 2005; 105: 4635-4641.
7. Sedivá A, Bartůnková J, Bartosová J, Jennette C, Falk RJ, Jethwa HS. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa. Microbes Infect 2003; 5: 27-30.